If you’ve been dealing with acne breakouts for years, you know it’s more than just a skin concern—it’s all-consuming. The ...

Sagimet Biosciences' FASN inhibitors show promise in acne and metabolic disease. Read my analysis on SGMT stock and see why I ...

The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to ...

If your tween or teen is suffering from acne, we’ve got the expert-backed answers you need to help your child achieve clearer ...

Ascletis said it has data indicating denifanstat is 98% more effective at treating acne than sarecycline, and 178% better ...

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced ...

In light of the promising results, Ascletis is planning to seek approval for denifanstat from the China National Medical Products Administration. Moreover, Sagimet has initiated a Phase 1 clinical ...

Implementing LGBTQ+ inclusive language in patient care and clinical trials for dermatology could improve data accuracy, ...

Worried about your teenager’s skin? Understanding what is causing their breakouts can make all the difference.

Shares of Sagimet Biosciences rose after the company disclosed what it called positive results from a recent clinical trial of its treatment for moderate-to-severe acne. The stock jumped 42%, to $5.20 ...

Back acne, also called bacne, can be tricky to treat because of its hard-to-reach location. Dermatologists share how to get ...

Kaya, India's leading chain of dermatology clinics, exclusively brings you Aerolase, a breakthrough laser treatment for ...